Antelope Enterprise Hldgs Ltd. buy krebskrebs
Start price
17.05.21
/
50%
€1.97
Target price
17.05.22
€3.00
Performance (%)
-67.06%
End price
18.05.22
€0.65
Summary
This prediction ended on 18.05.22 with a price of €0.65. The BUY prediction by krebskrebs for Antelope Enterprise Hldgs Ltd. performed very badly with a performance of -67.06%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Antelope Enterprise Hldgs Ltd. | - | - | - | - |
iShares Core DAX® | 1.937% | 1.473% | 18.596% | 15.757% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% | 35.363% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% | 10.532% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% | 36.692% |
Comments by krebskrebs for this prediction
In the thread Antelope Enterprise Hldgs Ltd. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Antelope Enterprise Hldgs Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten